Skip to main content
. 2021 May 26;9:667507. doi: 10.3389/fped.2021.667507

Table 4.

Proposed recommendations for clinical follow-up of PIMS-TS patients post-discharge.

Time since hospital discharge
Initial cardiac involvement (at diagnosis or during hospitalization) 1–2 weeks 4–6 weeks 3 months 6 months 12 months Exercise restrictiona General notes
(1) No cardiac involvement Echo, ECG, BP Consider 24 h-ECGb

Labsc
ASS
Echo, ECG, BP Consider 24 h-ECGb
Labsc
ASS = > consider stopping if no coronary artery abnormalities
Consider stopping follow-up at 4–6 weeks in patients without Kawasaki-like presentation; If coronary abnormalities at any time during follow-up = > follow AHA KD guidelines 2017 [see (5) below] 2 weeks Consider involvement of other specialities if initial and/or persistent organ system abnormalities
No live vaccines for 11 months following high-dose IVIG (2 g/kg)
(2) Myocardial injury (elevated cTnc ± NT-pro-BNP), normal ventricular function and normal coronary arteries
or
(3) Myocardial injury with initially depressed ventricular function, normalized systolic function at hospital discharge (diastolic dysfunction may persist)
Echo, ECG, BP Consider 24 h-ECGb


Labsc
ASS
Echo, ECG, BP Consider 24-h-ECGb

Labsc
ASS = > consider stopping if no coronary abnormalities
Echo, ECG, BP 24 h-ECGa Exercise stress testa
(Labsc)
Consider cardiac MRId
Echo, ECG, BP
Consider 24 h-ECGb

(Labsc)
Echo, ECG, BP
Consider 24 h-ECGb

(Labsc)
3–6 months
(4) Myocardial injury with persistent depressed ventricular function at hospital discharge Echo, ECG, BP Consider 24 h-ECGb

Labsc
ASS
Echo, ECG, BP
Consider 24 h-ECGb
Labsc
ASS = > consider stopping if no coronary abnormalities
Follow-up and sport restriction should be tailored based on the severity of the cardiac involvement and in line with guidelines for heart failure and myocarditis in children.
(5) Coronary artery involvement In addition to recommendations (1)–(4) above AHA guidelines 2017 should be respected with regards to follow-up, antiplatelet therapy/anticoagulation and exercise restriction.

ASS, acetylsalicylic acid; BP, blood pressure; CRP, C-reactive protein; Echo, echocardiography.

a

24 h-ECG and exercise stress test should be performed before returning to sports activity.

b

Consider 24 h-ECG if symptoms of arrythmia or abnormal ECG.

c

Laboratory investigations should include FBC, inflammatory markers (CRP) and cardiac enzymes (CK, CK-MB, cTnC, NT-pro-BNP) as well as other values not normalized at hospital discharge (such as coagulation, U/E, LFTs). Also consider performing urine testing if previously abnormal or signs of renal abnormalities.

d

MRI is considered in older patients without need for general anesthesia at 2–6 months post-discharge.